Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Fengcui Sun"'
Autor:
Lu Yu, Pengpeng Liang, Shizhao Zhang, Fengcui Sun, Chaoqun Ma, Xiufen Yang, Fengxia Zhang, Haifei Lu, Guoliang Yin, Yanan Feng
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Hyperlipidemia is a disorder of lipid metabolism, which is a major cause of coronary heart disease. Although there has been considerable progress in hyperlipidemia treatment, morbidity and risk associated with the condition continue to rise. The firs
Autor:
Yanan Feng, Wenxiu Sun, Fengcui Sun, Guoliang Yin, Pengpeng Liang, Suwen Chen, Xiangyi Liu, Tongfei Jiang, Fengxia Zhang
Publikováno v:
Drug design, development and therapy. 16
Non-alcoholic fatty liver disease (NAFLD), a spectrum of liver disorders from non-alcoholic fatty liver (NAFL) to the more severe non-alcoholic steatohepatitis (NASH), is the leading etiology of chronic liver disease and its global prevalence is incr
Autor:
Chaoqun Ma, Jingjing Shi, Shizhao Zhang, Xiufen Yang, Haifei Lu, Li Ruoqi, Fengcui Sun, Fengxia Zhang, Lu Yu, Yantong Yu
Publikováno v:
Toxicology and Applied Pharmacology. 414:115423
Autor:
Fengcui Sun, Chaoqun Ma, Jingjing Shi, Haifei Lu, Fengxia Zhang, Li Ruoqi, Lu Yu, Yantong Yu, Shizhao Zhang, Xiufen Yang
Publikováno v:
Toxicology and Applied Pharmacology. 412:115388
Phytosterol diosgenin (DG) exhibits cholesterol-lowering properties. Few studies focused on the underlying mechanism of DG attenuation of hypercholesterolemia by promoting cholesterol metabolism. To investigate the roles of SRB1/CES-1/CYP7A1/FXR path